Real-time enrollment status for this hepatocellular carcinoma clinical trial
Current Status
Recruiting
Checked: June 1, 2026 at 11:40 PM UTC
| NCT Number | NCT05440708 |
| Recruiting Status | Recruiting |
| Condition | Hepatocellular Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 178 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Tvardi Therapeutics, Incorporated |
| Last Updated on CT.gov | April 27, 2026 (Apr 27, 2026) |
As of June 1, 2026: Clinical trial NCT05440708 is currently recruiting participants. This clinical trial study for hepatocellular carcinoma is actively seeking new participants at 21 locations across the United States. The study is sponsored by Tvardi Therapeutics, Incorporated. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05440708 is actively recruiting participants as of June 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05440708 was last updated Apr 27, 2026 (April 27, 2026). HelloStudys verifies this status automatically.